<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 27 May 2026 08:00:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Erasca to Present at the Jefferies Global Healthcare Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/Erasca+to+Present+at+the+Jefferies+Global+Healthcare+Conference/26553734.html</link>
   <description>
&lt;p&gt;SAN DIEGO, May  27, 2026  (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the Jefferies Global Healthcare Conference being held at the Marriott Marquis in New York, NY. Management will participate in a fireside chat on Wednesday, June 3, 2026, at 3:10 pm Eastern Time and will also participate in one-on-one investor meetings.&lt;/p&gt;  &lt;p&gt;A live audio webcast of the event will be available online at &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=I1ouxzEQ5jk9nN8KkJdzT_leGNbXAnG0Acx7la1tlnOzTcjcstICFQ-z3XYonMuMDrVbEpzNascNK_zNVxXiErStUw7pwUa0A9xVXwVOTOXNe-9NR4eyr9WJOE0PK7ns&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Erasca.com/events&lt;/a&gt;. An archived replay of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Erasca+to+Present+at+the+Jefferies+Global+Healthcare+Conference/26553734.html</guid>
   <pubDate>Wed, 27 May 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216777</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39464001</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54516537</category>
   	  </item>
  <item>
   <title>Erasca to Present at the Jefferies Global Healthcare Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/Erasca+to+Present+at+the+Jefferies+Global+Healthcare+Conference/26553734.html</link>
   <description>
&lt;p&gt;SAN DIEGO, May  27, 2026  (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the Jefferies Global Healthcare Conference being held at the Marriott Marquis in New York, NY. Management will participate in a fireside chat on Wednesday, June 3, 2026, at 3:10 pm Eastern Time and will also participate in one-on-one investor meetings.&lt;/p&gt;  &lt;p&gt;A live audio webcast of the event will be available online at &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=I1ouxzEQ5jk9nN8KkJdzT_leGNbXAnG0Acx7la1tlnOzTcjcstICFQ-z3XYonMuMDrVbEpzNascNK_zNVxXiErStUw7pwUa0A9xVXwVOTOXNe-9NR4eyr9WJOE0PK7ns&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Erasca.com/events&lt;/a&gt;. An archived replay of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Erasca+to+Present+at+the+Jefferies+Global+Healthcare+Conference/26553734.html</guid>
   <pubDate>Wed, 27 May 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216777</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39464001</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54516537</category>
   	  </item>
  <item>
   <title>Erasca to Present at the Jefferies Global Healthcare Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/Erasca+to+Present+at+the+Jefferies+Global+Healthcare+Conference/26553734.html</link>
   <description>
&lt;p&gt;SAN DIEGO, May  27, 2026  (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the Jefferies Global Healthcare Conference being held at the Marriott Marquis in New York, NY. Management will participate in a fireside chat on Wednesday, June 3, 2026, at 3:10 pm Eastern Time and will also participate in one-on-one investor meetings.&lt;/p&gt;  &lt;p&gt;A live audio webcast of the event will be available online at &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=I1ouxzEQ5jk9nN8KkJdzT_leGNbXAnG0Acx7la1tlnOzTcjcstICFQ-z3XYonMuMDrVbEpzNascNK_zNVxXiErStUw7pwUa0A9xVXwVOTOXNe-9NR4eyr9WJOE0PK7ns&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Erasca.com/events&lt;/a&gt;. An archived replay of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Erasca+to+Present+at+the+Jefferies+Global+Healthcare+Conference/26553734.html</guid>
   <pubDate>Wed, 27 May 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216777</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39464001</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54516537</category>
   	  </item>
  <item>
   <title>Erasca to Present at the Jefferies Global Healthcare Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/Erasca+to+Present+at+the+Jefferies+Global+Healthcare+Conference/26553734.html</link>
   <description>
&lt;p&gt;SAN DIEGO, May  27, 2026  (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the Jefferies Global Healthcare Conference being held at the Marriott Marquis in New York, NY. Management will participate in a fireside chat on Wednesday, June 3, 2026, at 3:10 pm Eastern Time and will also participate in one-on-one investor meetings.&lt;/p&gt;  &lt;p&gt;A live audio webcast of the event will be available online at &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=I1ouxzEQ5jk9nN8KkJdzT_leGNbXAnG0Acx7la1tlnOzTcjcstICFQ-z3XYonMuMDrVbEpzNascNK_zNVxXiErStUw7pwUa0A9xVXwVOTOXNe-9NR4eyr9WJOE0PK7ns&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Erasca.com/events&lt;/a&gt;. An archived replay of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Erasca+to+Present+at+the+Jefferies+Global+Healthcare+Conference/26553734.html</guid>
   <pubDate>Wed, 27 May 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216777</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39464001</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54516537</category>
   	  </item>
  <item>
   <title>Erasca to Present at the Jefferies Global Healthcare Conference</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Erasca+to+Present+at+the+Jefferies+Global+Healthcare+Conference/26553734.html</link>
   <description>
&lt;p&gt;SAN DIEGO, May  27, 2026  (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the Jefferies Global Healthcare Conference being held at the Marriott Marquis in New York, NY. Management will participate in a fireside chat on Wednesday, June 3, 2026, at 3:10 pm Eastern Time and will also participate in one-on-one investor meetings.&lt;/p&gt;  &lt;p&gt;A live audio webcast of the event will be available online at &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=I1ouxzEQ5jk9nN8KkJdzT_leGNbXAnG0Acx7la1tlnOzTcjcstICFQ-z3XYonMuMDrVbEpzNascNK_zNVxXiErStUw7pwUa0A9xVXwVOTOXNe-9NR4eyr9WJOE0PK7ns&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Erasca.com/events&lt;/a&gt;. An archived replay of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Erasca+to+Present+at+the+Jefferies+Global+Healthcare+Conference/26553734.html</guid>
   <pubDate>Wed, 27 May 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216777</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39464001</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54516537</category>
   	  </item>
  <item>
   <title>Erasca to Present at the Jefferies Global Healthcare Conference</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Erasca+to+Present+at+the+Jefferies+Global+Healthcare+Conference/26553734.html</link>
   <description>
&lt;p&gt;SAN DIEGO, May  27, 2026  (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the Jefferies Global Healthcare Conference being held at the Marriott Marquis in New York, NY. Management will participate in a fireside chat on Wednesday, June 3, 2026, at 3:10 pm Eastern Time and will also participate in one-on-one investor meetings.&lt;/p&gt;  &lt;p&gt;A live audio webcast of the event will be available online at &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=I1ouxzEQ5jk9nN8KkJdzT_leGNbXAnG0Acx7la1tlnOzTcjcstICFQ-z3XYonMuMDrVbEpzNascNK_zNVxXiErStUw7pwUa0A9xVXwVOTOXNe-9NR4eyr9WJOE0PK7ns&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Erasca.com/events&lt;/a&gt;. An archived replay of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Erasca+to+Present+at+the+Jefferies+Global+Healthcare+Conference/26553734.html</guid>
   <pubDate>Wed, 27 May 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216777</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39464001</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54516537</category>
   	  </item>
  <item>
   <title>Erasca to Present at the Jefferies Global Healthcare Conference</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Erasca+to+Present+at+the+Jefferies+Global+Healthcare+Conference/26553734.html</link>
   <description>
&lt;p&gt;SAN DIEGO, May  27, 2026  (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the Jefferies Global Healthcare Conference being held at the Marriott Marquis in New York, NY. Management will participate in a fireside chat on Wednesday, June 3, 2026, at 3:10 pm Eastern Time and will also participate in one-on-one investor meetings.&lt;/p&gt;  &lt;p&gt;A live audio webcast of the event will be available online at &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=I1ouxzEQ5jk9nN8KkJdzT_leGNbXAnG0Acx7la1tlnOzTcjcstICFQ-z3XYonMuMDrVbEpzNascNK_zNVxXiErStUw7pwUa0A9xVXwVOTOXNe-9NR4eyr9WJOE0PK7ns&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Erasca.com/events&lt;/a&gt;. An archived replay of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Erasca+to+Present+at+the+Jefferies+Global+Healthcare+Conference/26553734.html</guid>
   <pubDate>Wed, 27 May 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216777</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39464001</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54516537</category>
   	  </item>
  <item>
   <title>Erasca to Present at the Jefferies Global Healthcare Conference</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Erasca+to+Present+at+the+Jefferies+Global+Healthcare+Conference/26553734.html</link>
   <description>
&lt;p&gt;SAN DIEGO, May  27, 2026  (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced its participation in the Jefferies Global Healthcare Conference being held at the Marriott Marquis in New York, NY. Management will participate in a fireside chat on Wednesday, June 3, 2026, at 3:10 pm Eastern Time and will also participate in one-on-one investor meetings.&lt;/p&gt;  &lt;p&gt;A live audio webcast of the event will be available online at &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=I1ouxzEQ5jk9nN8KkJdzT_leGNbXAnG0Acx7la1tlnOzTcjcstICFQ-z3XYonMuMDrVbEpzNascNK_zNVxXiErStUw7pwUa0A9xVXwVOTOXNe-9NR4eyr9WJOE0PK7ns&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;Erasca.com/events&lt;/a&gt;. An archived replay of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Erasca+to+Present+at+the+Jefferies+Global+Healthcare+Conference/26553734.html</guid>
   <pubDate>Wed, 27 May 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216777</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39464001</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.54516537</category>
   	  </item>
  <item>
   <title>Form  144        Erasca, Inc.                           Filed by: Erasca Foundation</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+Erasca+Foundation/26507160.html</link>
   <description>si-local-file:///var/storage/secattach/20260515/26507160.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+Erasca+Foundation/26507160.html</guid>
   <pubDate>Fri, 15 May 2026 16:47:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39464001</category>
   	  </item>
  <item>
   <title>Form  144        Erasca, Inc.                           Filed by: Erasca Foundation</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+Erasca+Foundation/26507160.html</link>
   <description>si-local-file:///var/storage/secattach/20260515/26507160.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+Erasca+Foundation/26507160.html</guid>
   <pubDate>Fri, 15 May 2026 16:47:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39464001</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Erasca, Inc.                           Filed by: Venrock Healthcare Capital Partners III, L.P.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+Venrock+Healthcare+Capital+Partners+III%2C+L.P./26506908.html</link>
   <description>si-local-file:///var/storage/secattach/20260515/26506908.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+Venrock+Healthcare+Capital+Partners+III%2C+L.P./26506908.html</guid>
   <pubDate>Fri, 15 May 2026 16:41:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39464001</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Erasca, Inc.                           Filed by: Venrock Healthcare Capital Partners III, L.P.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+Venrock+Healthcare+Capital+Partners+III%2C+L.P./26506908.html</link>
   <description>si-local-file:///var/storage/secattach/20260515/26506908.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+Venrock+Healthcare+Capital+Partners+III%2C+L.P./26506908.html</guid>
   <pubDate>Fri, 15 May 2026 16:41:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39464001</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Erasca, Inc.                           Filed by: Paradigm Biocapital Advisors LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+Paradigm+Biocapital+Advisors+LP/26506409.html</link>
   <description>si-local-file:///var/storage/secattach/20260515/26506409.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+Paradigm+Biocapital+Advisors+LP/26506409.html</guid>
   <pubDate>Fri, 15 May 2026 16:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39464001</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Erasca, Inc.                           Filed by: Paradigm Biocapital Advisors LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+Paradigm+Biocapital+Advisors+LP/26506409.html</link>
   <description>si-local-file:///var/storage/secattach/20260515/26506409.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+Paradigm+Biocapital+Advisors+LP/26506409.html</guid>
   <pubDate>Fri, 15 May 2026 16:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39464001</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Erasca, Inc.                           Filed by: T. Rowe Price Investment Management, Inc.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+T.+Rowe+Price+Investment+Management%2C+Inc./26501273.html</link>
   <description>si-local-file:///var/storage/secattach/20260515/26501273.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+T.+Rowe+Price+Investment+Management%2C+Inc./26501273.html</guid>
   <pubDate>Fri, 15 May 2026 10:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39464001</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Erasca, Inc.                           Filed by: T. Rowe Price Investment Management, Inc.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+T.+Rowe+Price+Investment+Management%2C+Inc./26501273.html</link>
   <description>si-local-file:///var/storage/secattach/20260515/26501273.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+T.+Rowe+Price+Investment+Management%2C+Inc./26501273.html</guid>
   <pubDate>Fri, 15 May 2026 10:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39464001</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  Erasca, Inc.                           Filed by: RTW INVESTMENTS, LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+RTW+INVESTMENTS%2C+LP/26499968.html</link>
   <description>si-local-file:///var/storage/secattach/20260515/26499968.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+RTW+INVESTMENTS%2C+LP/26499968.html</guid>
   <pubDate>Fri, 15 May 2026 08:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39464001</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G  Erasca, Inc.                           Filed by: RTW INVESTMENTS, LP</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+RTW+INVESTMENTS%2C+LP/26499968.html</link>
   <description>si-local-file:///var/storage/secattach/20260515/26499968.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13G++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+RTW+INVESTMENTS%2C+LP/26499968.html</guid>
   <pubDate>Fri, 15 May 2026 08:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39464001</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Erasca, Inc.                           Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+SUVRETTA+CAPITAL+MANAGEMENT%2C+LLC/26479716.html</link>
   <description>si-local-file:///var/storage/secattach/20260512/26479716.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+SUVRETTA+CAPITAL+MANAGEMENT%2C+LLC/26479716.html</guid>
   <pubDate>Tue, 12 May 2026 18:25:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39464001</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Erasca, Inc.                           Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+SUVRETTA+CAPITAL+MANAGEMENT%2C+LLC/26479716.html</link>
   <description>si-local-file:///var/storage/secattach/20260512/26479716.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Erasca%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+SUVRETTA+CAPITAL+MANAGEMENT%2C+LLC/26479716.html</guid>
   <pubDate>Tue, 12 May 2026 18:25:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39464001</category>
   	  </item>
  <item>
   <title>Erasca Inc (ERAS) PT Lowered to $26 at Mizuho</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Erasca+Inc+%28ERAS%29+PT+Lowered+to+%2426+at+Mizuho/26471773.html</link>
   <description>&lt;p&gt;Mizuho analyst Joseph Catanzaro lowered the price target on Erasca Inc (NASDAQ: ERAS) to $26.00 (from $28.00) while maintaining a Outperform rating.&lt;/p&gt;&lt;p&gt;The analyst comments &quot;ERAS reported 1Q26 EPS and provided a pipeline update. Commentary around expected updates from the Phase I studies of ERAS-0015 and ERAS-4001 was consistent with recent disclosures with the next look at ERAS-0015 in 1H27 and the first look at ERAS-4001 expected in 2H26. Given the initial look at ERAS-0015 and the exposures it is achieving at 24/32 mg, its safety profile and the early efficacy signal in NSCLC, we believe ERAS-0015 is positioned for a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Erasca+Inc+%28ERAS%29+PT+Lowered+to+%2426+at+Mizuho/26471773.html</guid>
   <pubDate>Tue, 12 May 2026 05:04:09 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	  </item>
  <item>
   <title>Erasca Inc (ERAS) PT Lowered to $26 at Mizuho</title>
   <link>http://www.streetinsider.com/Analyst+Comments/Erasca+Inc+%28ERAS%29+PT+Lowered+to+%2426+at+Mizuho/26471773.html</link>
   <description>&lt;p&gt;Mizuho analyst Joseph Catanzaro lowered the price target on Erasca Inc (NASDAQ: ERAS) to $26.00 (from $28.00) while maintaining a Outperform rating.&lt;/p&gt;&lt;p&gt;The analyst comments &quot;ERAS reported 1Q26 EPS and provided a pipeline update. Commentary around expected updates from the Phase I studies of ERAS-0015 and ERAS-4001 was consistent with recent disclosures with the next look at ERAS-0015 in 1H27 and the first look at ERAS-4001 expected in 2H26. Given the initial look at ERAS-0015 and the exposures it is achieving at 24/32 mg, its safety profile and the early efficacy signal in NSCLC, we believe ERAS-0015 is positioned for a</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/Erasca+Inc+%28ERAS%29+PT+Lowered+to+%2426+at+Mizuho/26471773.html</guid>
   <pubDate>Tue, 12 May 2026 05:04:09 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	  </item>
  <item>
   <title>Erasca, Inc. (ERAS) Misses Q1 EPS by 49c</title>
   <link>http://www.streetinsider.com/Earnings/Erasca%2C+Inc.+%28ERAS%29+Misses+Q1+EPS+by+49c/26469706.html</link>
   <description>&lt;p&gt;Erasca, Inc. (NASDAQ: ERAS) reported Q1 EPS of ($0.60), $0.49 worse than the analyst estimate of ($0.11).&lt;/p&gt;&lt;p&gt;For earnings history and earnings-related data on Erasca, Inc. (ERAS) &lt;a href=&quot;http://www.streetinsider.com/ec_earnings.php?q=ERAS&quot;&gt;click here&lt;/a&gt;.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Earnings/Erasca%2C+Inc.+%28ERAS%29+Misses+Q1+EPS+by+49c/26469706.html</guid>
   <pubDate>Mon, 11 May 2026 16:31:22 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	  </item>
  <item>
   <title>Form  10-Q       Erasca, Inc.              For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Erasca%2C+Inc.++++++++++++++For%3A+Mar+31/26469226.html</link>
   <description>si-local-file:///var/storage/secattach/20260511/26469226.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Erasca%2C+Inc.++++++++++++++For%3A+Mar+31/26469226.html</guid>
   <pubDate>Mon, 11 May 2026 16:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39464001</category>
   	  </item>
  <item>
   <title>Form  10-Q       Erasca, Inc.              For: Mar 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Erasca%2C+Inc.++++++++++++++For%3A+Mar+31/26469226.html</link>
   <description>si-local-file:///var/storage/secattach/20260511/26469226.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Erasca%2C+Inc.++++++++++++++For%3A+Mar+31/26469226.html</guid>
   <pubDate>Mon, 11 May 2026 16:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ERAS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.39464001</category>
   	  </item>
 </channel>
</rss>
